LENZ Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -10 | -18 | -5 | -142 |
EBITDA | -12,935 | -14,334 | -16,083 | -22,776 |
EBIT | -12,945 | -14,352 | -16,088 | -22,918 |
Net Income | -10,215 | -10,254 | -16,648 | -22,918 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -10,767 | -15,928 | -23,937 | -45,927 |
Cash | 41,046 | 84,149 | 200,357 | 185,861 |
Basic Shares | 27,172 | 25,608 | 4,717 | 8,286 |
Annual Financials
| Values in thousands | 2022-12-31 | 2021-12-31 |
|---|---|---|
Revenue | $15,000 | $0 |
Gross Profit | 6,654 | -734 |
EBITDA | -97,293 | -70,026 |
EBIT | -105,639 | -70,760 |
Net Income | -101,052 | -70,760 |
Net Change In Cash | 15,000 | 0 |
Free Cash Flow | -94,574 | -58,592 |
Cash | 47,730 | 376,976 |
Basic Shares | 7,839 | 8,287 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.37 |
2024-06-30 | -$0.40 |
2024-03-31 | -$3.53 |
2023-12-31 | -$0.40 |
